Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (462)	6/25/1999 1:21:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 717

David, As I've said many times before, PCYC price movements are totally mysterious to me. The only news since we were at $13 is that the Lutrin results were pretty much as expected, so it is not any recently announced news that is driving it. Maybe it's a delayed reaction to the Alcon program moving forward or some roto-rooter excitement/hype. Given its history of irrational price moves, with this stock even more than others, you really have to focus on the company not the stock price. As I think I said somewhere on SI when the price was around the mid teens, I felt this stock had a better shot at being a 10-bagger than any other that I followed. (A 10-bagger is always an unlikely event of course, and this stock is no exception to that). Peter